Several key milestones for the RPGRIP1 Program were achieved in 2021. Odylia Therapeutics will present a summary of these benchmarks and what it means for the program. We’ll also discuss the plans for 2022 including milestones, timelines, and the resources needed. Please share this information with anyone who might be interested or with your social media networks.

Meeting details:

Thursday, February 3, 2022

12:00pm – 1:00pm Eastern Standard Time (GMT-5)

Follow the link to receive zoom details for the meeting: https://odyliatherapeutics.salsalabs.org/rpgrip1feb22zoom/index.html